Intellectual Property
Treos’ IP portfolio (patent applications and allowed patents) covers our platform technologies and key product candidates: off-the shelf and personalized cancer immunotherapy products and preventive vaccine product.
| Subject Matter | IP status | Filing date |
| Personalized Immunogenic Peptide Identification Platform | Published. Pending PCT and US applications. Regional applications filed in 50+ countries. | 2 Mar 2018 |
| Off-the-shelf, Population-based Immunogenic Peptide Identification Platform | Published. Pending PCT and US applications. Regional applications filed in 50+ countries. | 2 Mar 2018 |
| “PEPI PANEL” Composition and Process for Selecting Peptides from PEPI PANEL Peptide Library for Off-the-shelf Personalized Cancer Treatments | Published. Pending PCT application. | 3 Sep 2019 |
| “HLAT screening” Immunogenetic Cancer Screening Test Determining a Subject’s Risk of Developing Cancer | Published. Pending PCT application. | 3 Sep 2019 |
| Compositions of Colorectal-, Breast-, Ovarian cancers Off-the-shelf Peptide immunotherapies | Published. PolyPEPI1018 CRC immunotherapy granted (US PTO). Pending PCT applications. Regional applications filed in 50+ countries. | 2 Mar 2018 |
| Compositions of Gastric-, Bladder-, Lung cancers & Melanoma Off-the-shelf Peptide Immunotherapies | Published. Pending PCT application. | 3 Sep 2019 |
| Composition of coronavirus vaccine product. | US Track One application. UK provisional application. | 3 Apr 2020 |
| Trade Secrets: Knowledgebase of peptide targets; Algorithm; Databases | Not applicable (N/A) | N/A |